Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids for acute ischaemic stroke.

N Qizilbash1, S L Lewington, J M Lopez-Arrieta

  • 1Department of Clinical Geratology, Radcliffe Infirmary, Oxford, UK, OX2 6HE. nawab.qizilbash@geratology.ox.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term follow-up in 2.6 million people.

European journal of neurology·2019
Same author

Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

WITHDRAWN: Tacrine for Alzheimer's disease.

The Cochrane database of systematic reviews·2007
Same author

A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

Journal of neurology, neurosurgery, and psychiatry·2006
Same author

Metrifonate for Alzheimer's disease.

The Cochrane database of systematic reviews·2006
Same author

Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack.

Cerebrovascular diseases (Basel, Switzerland)·2006
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Corticosteroids do not show a benefit in reducing death or improving functional outcomes for acute ischemic stroke patients. More research is needed to evaluate their effectiveness and safety in stroke treatment.

Area of Science:

  • Neurology
  • Clinical Medicine

Background:

  • Ischemic stroke causes brain swelling due to cytotoxic edema, linked to cell membrane dysfunction.
  • Corticosteroids are being investigated for their potential to reduce swelling and improve outcomes in stroke patients.

Purpose of the Study:

  • To review the efficacy of corticosteroid treatment in acute ischemic stroke.

Main Methods:

  • Searched the Cochrane Stroke Group trials register and contacted investigators.
  • Included randomized trials comparing corticosteroids with placebo in acute ischemic stroke patients treated within 48 hours.
  • Two reviewers assessed trial quality and extracted data.

Main Results:

  • Seven trials with 453 participants were analyzed.

Related Experiment Videos

  • No significant difference in one-year mortality (OR 1.08, 95% CI 0.68 to 1.72) was observed.
  • Functional outcomes and neurological impairment data were inconclusive due to inconsistent reporting and lack of standardized scales.

    • Conclusions:

    • Insufficient evidence exists to support or refute the use of corticosteroids in acute ischemic stroke.
    • Further high-quality trials are necessary to determine the role of corticosteroids in stroke management.